Turk Ilac ve Serumnayi (IST:TRILC) 5-Year EBITDA Growth Rate: 69.60% (As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IST:TRILC Turk Ilac ve Serum Sanayi IST:TRILC
62 GF Score
Price ₺1.07
GF Value ₺3.71
Valuation Possible Value Trap
! 11 Warning Signs
View Full Analysis

What is Turk Ilac ve Serumnayi 5-Year EBITDA Growth Rate?

Turk Ilac ve Serumnayi IST:TRILC -1.83% 62 5-Year EBITDA Growth Rate is 69.60% as of Sep. 2025. GuruFocus rates IST:TRILC with a GF Score™ of 62/100 and a GF Value™ of ₺3.71 (Possible Value Trap). The stock has 11 warning signs investors should review.

Turk Ilac ve Serumnayi's EBITDA per Share for the three months ended in Sep. 2025 was ₺0.49.

During the past 12 months, Turk Ilac ve Serumnayi's average EBITDA Per Share Growth Rate was 16.70% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 107.20% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 69.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 5 years, the highest 3-Year average EBITDA Per Share Growth Rate of Turk Ilac ve Serumnayi was 107.20% per year. The lowest was 66.20% per year. And the median was 86.70% per year.

Turk Ilac ve Serumnayi  (IST:TRILC) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Turk Ilac ve Serumnayi 5-Year EBITDA Growth Rate Related Terms

IST:TRILC vs ZTS, UTHR, VTRS: 5-Year EBITDA Growth Rate Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Turk Ilac ve Serumnayi's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Turk Ilac ve Serumnayi 5-Year EBITDA Growth Rate vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Turk Ilac ve Serumnayi's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Turk Ilac ve Serumnayi's 5-Year EBITDA Growth Rate falls into.


IST:TRILC
62GF Score
Turk Ilac ve Serum Sanayi IST:TRILC
5-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Turk Ilac ve Serumnayi 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of 69.60% mean?
Turk Ilac ve Serumnayi (IST:TRILC) has a 5-Year EBITDA Growth Rate of 69.60% as of Sep. 2025. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Turk Ilac ve Serumnayi and its competitors.
Is Turk Ilac ve Serumnayi's 5-Year EBITDA Growth Rate too high?
Turk Ilac ve Serumnayi's current 5-Year EBITDA Growth Rate is 69.60%. Overall, Turk Ilac ve Serumnayi has a GF Score™ of 62/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Turk Ilac ve Serumnayi's 5-Year EBITDA Growth Rate compare to ZTS and UTHR?
Turk Ilac ve Serumnayi's 5-Year EBITDA Growth Rate of 69.60% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Drug Manufacturers company?
A good 5-Year EBITDA Growth Rate depends on the Drug Manufacturers industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Turk Ilac ve Serumnayi and its competitors. Turk Ilac ve Serumnayi's current 5-Year EBITDA Growth Rate is 69.60%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Turk Ilac ve Serumnayi stock overvalued right now?
Based on GuruFocus' analysis, Turk Ilac ve Serumnayi (IST:TRILC) is currently considered Possible Value Trap. The stock's GF Value™ is ₺3.71, compared to a current price of ₺1.07 — trading 71.2% below its estimated fair value. The current 5-Year EBITDA Growth Rate is 69.60%. Turk Ilac ve Serumnayi's overall GF Score™ is 62/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Turk Ilac ve Serumnayi (IST:TRILC), the current 5-Year EBITDA Growth Rate is 69.60% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Turk Ilac ve Serumnayi (IST:TRILC) Overvalued in 2026?

Based on GuruFocus' analysis, Turk Ilac ve Serumnayi stock appears to be undervalued. The current stock price of ₺1.07 is trading 71.2% below its estimated GF Value™ of ₺3.71. GuruFocus considers Turk Ilac ve Serumnayi to be Possible Value Trap.

Key valuation signals for IST:TRILC:

  • 5-Year EBITDA Growth Rate: 69.60%
  • GF Value™: ₺3.71 vs. price of ₺1.07 (71.2% below fair value)
  • GF Score™: 62/100 with 11 warning signs

No single metric tells the full story. See the IST:TRILC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Turk Ilac ve Serumnayi Business Description

Address Bugduz Mahalle Enver Pasa Cadde, No: 8 Akyurt, Ankara, TUR, TR 06750
Turk Ilac ve Serum Sanayi is engaged in the production of human pharmaceuticals and vaccines.
62GF Score

Get the complete analysis for IST:TRILC

5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₺1.07
Price
₺3.71
GF Value